29 April 2021
|
2
min read
The NHS, in collaboration with UK biotech company Genomics plc, has launched a pilot study to improve the prediction of heart disease risk using a new integrated tool that combines polygenic and clinical risk scores. The trial represents a major step toward incorporating genomic data into routine healthcare for prevention and early intervention.
This article was published by NHS Genomics Education.
